GGrantIndex
← Search

Cellular Prion Protein Targeting Monoclonal Antibody Antagonist as a Therapy for Alzheimer's Disease

$449,995R44FY2020AGNIH

Allyx Biosciences, Inc., New Haven CT

Investigators

View original record on NIH RePORTER →
Cellular Prion Protein Targeting Monoclonal Antibody Antagonist as a Therapy for Alzheimer's Disease · GrantIndex